Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Grigorios Chlouverakis"'
Autor:
Dimitris Mavroudis, Vassilis Georgoulias, Evi Lianidou, Efstathios Stathopoulos, Grigorios Chlouverakis, Maria Kafousi, Stella Apostolaki, Maria Perraki, Maria Ntoulia, Galatea Kallergi, Michail Ignatiadis
Supplementary Figures S1-S2 from Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0fe36b03e76cb4f5245dc378ec2c16e
https://doi.org/10.1158/1078-0432.22439466
https://doi.org/10.1158/1078-0432.22439466
Autor:
Kostas Kalbakis, Grigorios Chlouverakis, Efstathios N. Stathopoulos, Dimitris Mavroudis, S. Kakolyris, Evi Lianidou, Sofia S. Agelaki, Nikolaos Xenidis, Stella Apostolaki, M. Perraki, Vassilis Georgoulias, Michail Ignatiadis
Publikováno v:
Journal of Clinical Oncology. 27:2177-2184
Purpose To evaluate the prognostic significance of cytokeratin-19 (CK-19) mRNA-positive circulating tumor cells (CTCs) in peripheral blood of women with early-stage breast cancer after the completion of adjuvant chemotherapy. Patients and Methods Blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94506df9dff731307aae3c2d810f3bb7
https://doi.org/10.1200/jco.2008.18.0497
https://doi.org/10.1200/jco.2008.18.0497
Autor:
M. Perraki, Vassilis Georgoulias, Galatea Kallergi, Stella Apostolaki, Michail Ignatiadis, Maria Kafousi, Efstathios N. Stathopoulos, Evi Lianidou, Grigorios Chlouverakis, Maria Ntoulia, Dimitris Mavroudis
Publikováno v:
Clinical Cancer Research. 14:2593-2600
Purpose: To investigate the prognostic value of the molecular detection of circulating tumor cells (CTCs) using three markers [cytokeratin 19 (CK19), mammaglobin A (MGB1), and HER2] in early breast cancer. Experimental Design: CK19mRNA+, MGB1mRNA+, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9af2c24a6d4e9fa7261e7a9bcc9f232
https://doi.org/10.1158/1078-0432.ccr-07-4758
https://doi.org/10.1158/1078-0432.ccr-07-4758
Autor:
Dimitris Mavroudis, Stella Apostolaki, Grigorios Chlouverakis, Eleni Politaki, Michail Ignatiadis, Evi Lianidou, Maria Kafousi, Efstathios N. Stathopoulos, M. Perraki, Vassilis Georgoulias, Christos Sotiriou, N. Xenidis, Aliki Stathopoulou
Publikováno v:
Journal of Clinical Oncology. 25:5194-5202
Purpose To examine the prognostic value of cytokeratin-19 (CK-19) mRNA–positive circulating tumor cells (CTCs) in early-stage breast cancer patients focusing on clinically relevant subgroups based on estrogen receptor (ER) and HER2 expression. Pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41a255066754cf83af24fcc17d7cefc
https://doi.org/10.1200/jco.2007.11.7762
https://doi.org/10.1200/jco.2007.11.7762
Autor:
Nikolaos E. Igoumenidis, Ioannis Loggakis, Michalis Hamilos, Panos E. Vardas, George E. Kochiadakis, Grigorios Chlouverakis, Marios Kambouris, Ilias G. Saloustros, Despina Vougia, Emmanuel I. Skalidis
Publikováno v:
Journal of thrombosis and thrombolysis. 40(3)
It is well known that patients with poor response to antiplatelet therapy are most likely to have more thrombotic events. Clopidogrel hydrogensulfate (CHS) is a thienopyridine acting as an important antiplatelet agent alone or in combination with ace
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::784bf3ca8bd653145aedf109580f61fe
https://pubmed.ncbi.nlm.nih.gov/25662861
https://pubmed.ncbi.nlm.nih.gov/25662861